Pathstone Family Office’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$295K Buy
+2,349
New +$321K ﹤0.01% 1316
2023
Q1
Sell
-1,747
Closed -$251K 1507
2022
Q4
$251K Buy
+1,747
New +$206K ﹤0.01% 1301
2021
Q4
Sell
-2,996
Closed -$415K 962
2021
Q3
$415K Buy
+2,996
New +$453K 0.01% 578
2021
Q1
Sell
-312
Closed -$43K 1312
2020
Q4
$43K Buy
312
+14
+5% +$1.74K ﹤0.01% 547
2020
Q3
$32K Hold
298
﹤0.01% 418
2020
Q2
$28K Hold
298
﹤0.01% 384
2020
Q1
$30K Hold
298
﹤0.01% 371
2019
Q4
$428K Sell
298
-125
-30% -$17.8K ﹤0.01% 319
2019
Q3
$63K Hold
423
0.01% 242
2019
Q2
$55K Buy
423
+125
+42% +$15.7K 0.01% 314
2019
Q1
$40K Buy
+298
New +$39.2K 0.01% 335
2017
Q2
Sell
-3
Closed 631
2017
Q1
$0 Buy
+3
New +$355 ﹤0.01% 623

Other funds holding UHS

Pathstone Family Office's UHS Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Universal Health Services (UHS) in Q3 2023: 2,349 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #1316 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in UHS as recently as Q4 2022.

Pathstone Family Office first reported a position in UHS in Q1 2017 and has held it in 12 quarters since. The position peaked at $428K in Q4 2019. 439 funds tracked by Wall St. Rank hold UHS as of Q3 2023.

  • Pathstone Family Office held 2,349 shares of Universal Health Services worth $295K as of Q3 2023.
  • Universal Health Services was a new Pathstone Family Office position in Q3 2023.
  • Universal Health Services made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1316 holding.
  • Pathstone Family Office first reported a position in Universal Health Services in Q1 2017 and has held it in 12 quarters since.
  • Pathstone Family Office's Universal Health Services position peaked at $428K in Q4 2019.
  • 439 funds tracked by Wall St. Rank held Universal Health Services as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.